Connection

Sharon Yeatts to Iron Chelating Agents

Back to Details
This is a "connection" page, showing publications Sharon Yeatts has written about Iron Chelating Agents.
Sharon Yeatts
Connection Strength
0.164
Iron Chelating Agents
  1. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019 05; 18(5):428-438.
    View in: PubMed
    Score: 0.164
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.